QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients 期刊论文 2019, 卷号: 111, 期号: 1, 页码: 86-94 作者:  Lambertini, Matteo;  Campbell, Christine;  Bines, Jose;  Korde, Larissa A.;  Izquierdo, Miguel 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03 Updated results from the phase III ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T -> L) or their combination (L plus T) in the adjuvant tre 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20 作者:  Moreno-Aspitia, Alvaro;  Holmes, Eileen McCormick;  Jackisch, Christian;  De Azambuja, Evandro;  Boyle, Frances M. 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 Updated results from the phase III ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T -> L) or their combination (L plus T) in the adjuvant tre 期刊论文 2017, 卷号: 35 作者:  Moreno-Aspitia, Alvaro;  Holmes, Eileen McCormick;  Jackisch, Christian;  De Azambuja, Evandro;  Boyle, Frances M. 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04